AusBiotech Welcomes New Members In First Quarter

In the first quarter of this year, AusBiotech proudly welcomed a significant number of new members.

Our latest members span biotechnology, medical technology, pharmaceuticals, digital health, research and professional services, highlighting the continued growth and diversity of our ecosystem in Australia.

We are thrilled to introduce the following new members:

  • Aurora Biosynthetics Pty Ltd
  • Emball'iso
  • Pulse Economics Consulting
  • BioNTech Australia Pty Ltd
  • AdvanCell Pty Limited
  • Adherium Limited
  • Facio BioTherapies Pty Ltd
  • Sartorius Australia Pty Ltd
  • New England Biolabs (Australia)
  • Miltenyi Biotec Australia Pty Ltd
  • Proclinical
  • Cicada Innovations
  • Prove Clinical Laboratories Pty Ltd
  • Celleo Biotech
  • Vertex Pharmaceuticals (Australia) Pty Limited
  • Mark Wainwright Analytical Centre

Joining AusBiotech creates new connections across the life science ecosystem, helps members stay informed of current trends and issues, and supports the advocacy that promotes our growing life science industry in Australia.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.